Ciclopirox Olamine
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 632 publications
Mass Spectrometry-Based Screening Reveals Inhibitors of Cholesterol 25-Hydroxylase.
Journal: ACS chemical biology
Published: June 12, 2026
Atypical cutaneous candidiasis mimicking tinea corporis in an otherwise healthy young man: A case report.
Journal: Medical mycology case reports
Published: May 20, 2026
FDA-approved drug library screen identifies antidepressants, antimicrobials, anti-COPD, and anti-CVD agents as blockers of NLRP3 inflammasome and sepsis in a sex-dependent manner.
Journal: bioRxiv : the preprint server for biology
Published: March 23, 2026
Preliminary Functional Screening of Autochthonous Saccharomyces cerevisiae from Mexican Cocoa Bean Fermentation for Traits Associated with Probiotic Potential.
Journal: Microorganisms
Published: March 05, 2026
Combination therapy using Ciclopirox and Salicylic acid incorporated Chitosan lotion for onychomycosis treatment.
Journal: International journal of biological macromolecules
Published: March 03, 2026
Telemedicine visits for new onychomycosis diagnoses result in fewer antifungal prescriptions than in-person care: A retrospective cohort study.
Journal: JAAD international
Published: January 21, 2026
Ciclopirox Olamine Inhibits the NLRP3 Inflammasome to Alleviate Inflammatory Diseases.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 17, 2025
Nail tattooing: a novel and minimally invasive technique for enhancing drug penetration through the nail.
Journal: Drug delivery and translational research
Published: December 12, 2025
Evaluation of In Vitro Efficiency of Ciclopirox Against Yersinia pestis and Francisella tularensis.
Journal: International journal of molecular sciences
Published: December 03, 2025
Lipid nanoparticle co-delivery of mRNA and a small molecule drug for oral cancer chemoimmunotherapy.
Lipid nanoparticle co-delivery of mRNA and a small molecule drug for oral cancer chemoimmunotherapy.
Journal: bioRxiv : the preprint server for biology
Published: November 19, 2025
Effect of the antifungal drug ciclopirox on the inhibition of HMGA2-mediated oncogenic capacity in ACHN renal cell carcinoma.
Journal: Frontiers in pharmacology
Published: October 13, 2025
Last Updated: 06/30/2026